ANIXAnixa Biosciences Inc同业对比
Anixa Biosciences Inc 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANIX本股 | $117M#7 | — | 8.1x#10 | 558.1x#7 | 0.0%#6 | 13.0%#6 | -5571.9%#8 | -75.5%#9 | -87.5%#1 | — | — | — |
| GNLX | $132M#4 | — | 5.7x#9 | 16450.8x#8 | 0.0%#6 | -7.6%#8 | -415175.0%#9 | -140.2%#10 | -228.3%#3 | — | — | — |
| MIST | $138M#1 | — | 3.8x#7 | — | — | -51.9%#12 | — | -0.2%#2 | -271.1%#4 | — | — | — |
| UNCY | $134M#3 | — | 3.6x#6 | 198.4x#6 | -29.0%#8 | 27.7%#5 | -4372.9%#7 | -70.4%#8 | — | — | — | — |
| PMN | $124M#5 | — | 2.0x#5 | — | — | -1529.3%#14 | — | -65.4%#6 | — | — | — | — |
| PEPG | $122M#6 | — | 0.9x#3 | — | — | 0.4%#7 | — | -66.9%#7 | — | — | — | — |
| PLYX | $110M#9 | — | 44.1x#12 | — | — | 70.4%#2 | — | -361.1%#13 | — | — | — | — |
| CNTN | $135M#2 | — | 0.3x#1 | — | — | -194.5%#13 | — | -7.6%#3 | — | — | 46.6%#1 | — |
| NRXP | $114M#8 | — | — | 93.3x#5 | — | -13.9%#9 | -1324.4%#5 | — | — | — | — | — |
| FBIO | — | 1.0x#2 | — | — | 9.7%#4 | 76.2%#1 | -111.0%#3 | 22.8%#1 | — | — | — | — |
| CPIX | $101M#10 | — | 4.7x#8 | 2.3x#2 | 17.6%#3 | 56.2%#4 | -6.3%#2 | -13.1%#4 | — | — | — | — |
| ERNA | $4M#13 | 0.1x#1 | 0.6x#2 | 6.8x#3 | 755.9%#1 | 68.4%#3 | -1601.2%#6 | -205.3%#11 | -203.6%#2 | — | -92.1%#4 | — |
| COYA | $99M#11 | — | 2.0x#4 | 12.4x#4 | 123.6%#2 | -42.6%#10 | -283.9%#4 | -43.3%#5 | — | — | -30.6%#2 | — |
| HRTX | $94M#12 | — | 10.3x#11 | 0.6x#1 | 7.4%#5 | -42.9%#11 | -1.6%#1 | -218.9%#12 | — | — | -71.2%#3 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-08-02。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议